RxDoctor Payments Data

Ma Isabel Obligacion, NP

Family · Federal Way, WANPI 1760017115

Payments from drug & device makers

$1,183in general payments, 2019–2025

Across 48 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$223
  • Novo Nordisk$150
  • Johnson & Johnson$122
  • Sumitomo Pharma America, Inc.$85
  • AstraZeneca$70
  • Xeris Pharmaceuticals, Inc.$66
  • plus $467 from 10 others

What the payments were for

  • Food & beverage$1,183100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,183 in reported general payments places this provider in the 80th percentile of 1,706 family providers in Washington.

See all family providers in Washington

Medicare billing

Part B allowed, 2024
$22,277
Medicare patients
34
Services billed
255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol30$31,376
OzempicSemaglutide22$29,566
EliquisApixaban13$22,622
JardianceEmpagliflozin19$20,050
TradjentaLinagliptin12$12,523
Febuxostat13$2,206
Metformin Hcl64$983
Losartan Potassium66$936
Albuterol Sulfate HfaAlbuterol Sulfate31$898
Pravastatin Sodium88$837
Atorvastatin Calcium69$653
Omeprazole29$590
Rosuvastatin Calcium51$559
Oxycodone Hcl38$555
Alendronate Sodium48$455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$58$32,57331 claims
AstraZenecaFarxiga$70$31,37630 claims
Novo NordiskOzempic$150$29,56622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,706 family providers in Washington.

Other family in Federal Way

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →